SFTPD and endothelial dysfunction: Furthermore, our findings revealed that biomarkers reflecting fibroproliferative processes (VEGF, uPAR, galectin-3, E-selectin, and surfactant protein D), endothelial dysfunction (ANG-2, PECAM-1, and ICAM-1), and D-dimer were also associated with increased mortality risk.